Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache

OBJECTIVE: To determine the safety of domperidone in the treatment of nausea associated with dihydroergotamine (DHE) infusion and headache. METHODS: We audited our use of domperidone for the inpatient management of nausea, focusing on known safety concerns, particularly potential cardiac arrhythmias...

Descripción completa

Detalles Bibliográficos
Autores principales: Robbins, Nathaniel M., Ito, Hiroyuki, Scheinman, Melvin M., Goadsby, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206996/
https://www.ncbi.nlm.nih.gov/pubmed/27837002
http://dx.doi.org/10.1212/WNL.0000000000003429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206996/
https://www.ncbi.nlm.nih.gov/pubmed/27837002
http://dx.doi.org/10.1212/WNL.0000000000003429

Ejemplares similares